Abstract-Pharmacological profile of a new sympathomimetic agent, compound 70-352, is reported herein. This compound was found to directly stimulate a-ad renergic receptors in the cat, guinea pig, rabbit and rat. Activity was similar to that of noradrenaline (NA) but it was only 0.032% as potent as NA on isolated rat uterus. Duration of action of the compound was, however, much longer. Compound 70 -352 had no effect on the central nervous system and the acute LD<SUB>50</SUB> in mice was 1000.0 mg/kg i.p.
Synthesis and preliminary pharmacological data of a new cyclohepten derivative (corn. MATERIALS AND METHODS Pharmacological properties of compound 70-352 were studied in cat, guinea pig, rabbit, rat and mice. The compound was used as a freshly prepared aqueous solution (pl-I-5.5). 1) Studies in cats (a) Normal cats: Cats of both sexes weighing between 2.5 and 4.0 kg were anaesthetised with pentobarbitone sodium (35.0 mg/kg i.v.). Blood pressure (BP) was recorded from the left common carotid artery through a Statham P23dc transducer on a Grass Model 7 polygraph. A polythene tube was inserted into one of the femoral veins for drug ad ministration. An endotracheal tube was inserted for use in every experiment either to record respiration through a Grass PT05 volume transducer on another channel of the polygraph or to give positive pressure respiration from a pump. Contractions of the nictitating membrane (NM) of right side were recorded through a Grass FT03 force-displacement transducer on the polygra.tph. Preganglionic sympathetic fibres were stimulated (5-10 V, I cosec, 1020;sec for 5 sees) by square wave impulses derived from a Grass S44 electronic stimulator. In some experiments, heart rate (IIR) was recorded by means of a Grass 7 NA Tachograph pre-amplifier. Responses of noradrenaline (2-4 /ig) (NA) adrenaline (2 4 /tg) (A) and tyramine (0.1 1.0 nag) (TYR) on BP, HR and NM were also studied. lmipramine (1.0 mg/kg i.v.) pretreatment was done acutely one hr prior to admin istration of the compound in anaesthetised cats.
(cl) Localisation of the conrpolold in the central Nervous system (CNS): The compound was localised in the CNS by administration through a Collison's cannula implanted ac cording to the technique of' Feldberg and Sherwood (4) in a lateral cerebral ventricle (icv). The total volume injected at a time did not exceed 0.3 ml.
In some cats the compound was administered into a vertebral artery by means of a polythene tube introduced through the brachial artery with the tip close to the origin of the vertebral artery. All branches of the subclavian artery except the common carotid were ligated. The common carotid artery was occluded during the time of injection of the compound.
(e) Localisation of the compound to superior cervical ganglion: A retrograde injection of the compound via the lingual artery was given according to the method described by Trendelenburg (5) . Effect of the compound on the NM was studied.
(f) Effect on heart in vivo: Chest of anaesthetised cats under artificial respiration was opened by a mid-line incision. Contractions of the right auricle and ventricle were re corded by means of Grass FT03 force displacement transducers on the polygraph. 2) Studies ill guinea piti.S (a) Konzett-Rossler preparation: Guinea pigs were anaesthetised with urethane (7.0 nil/kg of 25 ° ; solution i.p.). A jugular vein was cannulated for drug administration. A Y-shaped glass cannula with a side limb was passed in the trachea and the experiment set up as described by Konzett and Rossler (6) .
(h) Isolated heart: Guinea pigs were stunned by a blow on the head; the necks incised and the hearts removed quickly. These were then perfused at 37'C with oxygenated Ring er-Locke's solution in a Langendorff apparatus. 5) Effect of the compound on superior cervical ganglion The compound when localised to superior cervical ganglion failed to produce con traction of the NM up to a dose of 100 jig. Higher closes produced contraction of the NM as well as hypertension.
6) Effect of the compound on heart
Compound 70-352 produced a positive inotropic and chronotropic effect on the auricle as well as ventricle in the (open chest) cat heart (Fig. 4) . The effect was similar to that produced by NA, moreover, the effect of NA was potentiated by the compound. The relaxant effect of both agents was blocked by tolazoline (1.0 ,gig/ml) as shown in Fig. 8 . DCI, however, failed to block the effects.
10) Effect on the isolated rat uterus
Compound 70-352 as well as NA were devoid of any effect on the isolated rat uterus but both antagonised the Ach in duced contractions in a graded manner.
FIG. 8. Spontaneous contractions of rabbit isolated duodenum.
Upper panels show the effect of compound 70 352 (250 ''gi ml) and lower panels the effect of nor adrenaline (0.25 ,og;'ml ). Between 1st and 2nd panels tolazoline (I og/ml) was added to the bath. Dots denote the place where the agonists were added, while triangles denote the point where the tissue was washed. Note that tolazoline inhibits the relaxation produced by the compound as well as noradrenaline.
Partial recovery at 20 min is depicted in panels on far right. The molar log concentration of the two agents has been plotted against "" inhibition in 
DISCUSSION
Sympathomimetic agents can either act directly like NA and A or indirectly like TYR. The results of this study indicate that compound 70-352 is a directly acting sympathomi metic agent. It raised the blood pressure and caused mydriasis and contracture of the NM of cat. The effect on NM was not obtained following close intra-arterial injection of the compound to the ganglion or its localisation to the central nervous system, indicat ing it to be a peripheral effect. The stimulant effect on the heart was evident in vivo as well as in vitro. It did not produce a tolerance in cats with repeated administration. Like other directly acting sympathornimetic agents, compound 70-352 was also more effective in spinal transected and reserpine or imipramine pretreated animals.
The predominant effect of the compound appeared to be a-adrenergic receptor stimu lation. The pressor effect in the cat could be substantially blocked by a-adrenergic re ceptor blocking agents like dibenamine and yohimbine. Similarly the NM contraction was substantially blocked by a-adrenergic blocking agents. The relaxant effect on rabbit duodenum was also mediated via cc-adrenergic receptors since it could be blocked by tola zoline but not by the j-adrenergic blocking agent DCI. The central effects of compound 70-352 (vide results) also resemble those of NA, which is well known to produce depres sion in high doses and to be devoid of any effect on gross behaviour in low doses and, there fore, likely to be mediated by ct-adrenoceptors.
The similarity of action between NA and compound 70-352 was demonstrated in several experimental models. Thus both of them had a qualitatively similar effect on BP, heart and other smooth muscles. The effect of both agents could be blocked to an al most equal degree by cr-adrenergic blocking agents at most of the sites and by fl-adrenergic blocking agent on the heart. The spasmogenic effect of histamine on guinea pig bronchi in Konzett-Rossler preparation could be prevented both by NA and the compound. Simi larly both these agents antagonised Ach induced contractions of isolated rat uterus. The regression lines drawn with the two agents were parallel, suggesting the same mechanism of action although the potency of the compound, on wt. basis, is only a fraction of that of NA (1: 0.00032). Moreover, the compound potentiated the effect of NA, A, as well as TYR on the BP, heart and NM (Figs. 2 and 4) .
It was interesting to observe that the compound could restore the TYR responses in reserpinised cats (Fig. 3) indicating that it was to some extent able to replace the depleted NA in the stores. Bhagat et al. (7) obtained similar results with v-methyl noradrenaline and suggested that cc-methyl noradrenaline was being taken up by the catecholamine up take mechanism in the adrenergic nerve terminals. Compound 70/352 can also be pre sumably taken up by a similar mechanism and can be released from the site by TYR as is the case with NA.
These results suggest that compound 70/352 occupies the NA receptor both in the adrenergic neuroeffector junctions as well as in the uptake mechanism of the neurons. Even though NA and compound 70/352 have structural similarity (Fig. 1) , the ethylamine chain is a part of a rigid framework in compound 70/352 and therefore, the molecule will have a substantially different steric configuration from NA.
This will have to be borne in mind while finalising the structure of the NA receptor at both these sites.
